Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

stock-incyte-01-shutter

Incyte receives EC approval for Pemazyre

March 30, 2021 Manufacturing and Production EU

Incyte have received approval from the European Commission (EC) for Pemazyre (pemigatinib), the first new treatment for adults with locally …
News

Zealand’s Zegalogue treatment for hypoglycemia approved by FDA

March 23, 2021 Manufacturing and Production FDA, Zealand Pharma, Zegalogue

The FDA have approved Zealand Pharma’s Zegalogue therapy for the treatment of severe hypoglycemia in patients with diabetes.
News
stock-incyte-01-shutter

Incyte biliary tract cancer treatment approved in Japan

March 23, 2021 Manufacturing and Production EMA, Japan, oncology

The Japanese Ministry of Health, Labour, and Welfare (MHLW) have approved Incyte’s Pemazyre (pemigatinib) for the treatment of patients with …
News
img_4190-e1376666350337-web

Accord Healthcare launches thalidomide for multiple myeloma treatment

March 23, 2021 Manufacturing and Production MHRA, oncology

Accord Healthcare has announced the UK launch of a generic thalidomide, which is used in combination with melphalan and prednisone, …
News
Roche's building

Roche’s Huntington’s disease treatment disappoints in Phase III trial

March 23, 2021 Manufacturing and Production Huntington's, Phase III trial, Roche, huntington's disease, tominersen

Roche has discontinued dosing in a Phase III trial of its tominersen treatment for Huntington’s disease, following discouraging initial data.
News

Novartis prostate cancer treatment sees positive Phase III results

March 23, 2021 Manufacturing and Production Novartis, oncology

Novartis has today announced positive results from its Phase III VISION study with 177Lu-PSMA-617, seeing significant improvements in overall survival …
News
Janssen sign

Johnson & Johnson’s arthritis drug shows promising results in Phase III trial

March 16, 2021 Manufacturing and Production Janssen, Johnson & Johnson, PSA, Tremfya, arthritis

Johnson & Johnson’s TREMFYA treatment for active Psoriatic Arthritis (PsA) has returned positive results in its Phase III trial.
News

Roche and PTC’s SMA treatment shows positive trial results

March 16, 2021 Manufacturing and Production PTC, PTC Therapeutics, Roche, sma, spinal muscular atrophy

Roche and PTC Therapeutics’s Evrysdi treatment for children and adults with Type 2 or Type 3 spinal muscular atrophy (SMA) …
News
az

AstraZeneca vaccine suspended in 11 European countries

March 16, 2021 Manufacturing and Production AstraZeneca

Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine. France, Germany, Italy, and …
News
gilead-sciences

Gilead and MSD partner to develop and commercialise two-drug HIV regimen

March 16, 2021 Manufacturing and Production Gilead, HIV, MSD

Gilead and MSD, known as Merck in the US and Canada, have entered into an agreement to co-develop and co-commercialise …
News

Perception and Otsuka enter collaboration and licensing deal for depression drug candidate

March 16, 2021 Manufacturing and Production CNS, Otsuka Pharmaceutical, Perception Neuroscience, depression

Perception Neuroscience and Otsuka Pharmaceutical have announced a collaboration and licensing agreement for the development and commercialisation of Perception’s lead …
News

CytoDyn’s COVID-19 treatment shows positive results in Phase III trial

March 9, 2021 Manufacturing and Production cytodyn, phase 3 trial, vyrologix

Biotechnology company CytoDyn has shown positive results in its Phase III CD12 trial of Vyrologix, its treatment for COVID-19 patients …
News
FDA building

FDA approves Kite’s Yescarta therapy for follicular lymphoma

March 9, 2021 Manufacturing and Production FDA, Kite, Yescarta

The FDA has granted accelerated approval to Kite’s Yescarta treatment, a medicine for adult patients with relapsed or refractory follicular …
News
nuts-1736520_1920

Camallergy awarded £1.1m government funding for peanut allergy immunotherapy

March 9, 2021 Manufacturing and Production Camallergy, UK, allergy

Camallergy, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded …
News

Valo and ImmunoScape collaboration identifies immunogenic peptides for pan-coronavirus vaccine

March 9, 2021 Manufacturing and Production COVID-19, Valo Therapeutics, immunoscape, vaccines

Immunotherapy platform developer Valo Therapeutics has successfully completed a collaboration with the biotechnology company ImmunoScape to identify immunogenic peptides for …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026